Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2004-11-26
pubmed:abstractText
Porcine endogenous retroviruses (PERVs) pose a potential stumbling block for therapeutic xenotransplantation, with the greatest threat coming from viruses generated by recombination between members of the PERV subgroup A (PERV-A) and PERV-C families (PERV-A/C recombinants). PERV-A and PERV-B have been shown to infect human cells in culture, albeit with low titers. PERV-C has a more restricted host range and cannot infect human cells. A recombinant PERV-A/C virus (PERV-A14/220) contains the PERV-A sequence between the end of pol and the middle of the SU region in env. The remaining sequence is derived from PERV-C. PERV-A14/220 is approximately 500-fold more infectious than PERV-A. To determine the molecular basis for the increased infectivity of PERV-A14/220, we have made a series of vector constructs. The primary determinant for the enhanced replicative potential of the recombinant virus appeared to be the env gene. Using a series of chimeric env genes, we could identify two determinants of high infectivity; one was an isoleucine to valine substitution at position 140 between variable regions A and B, and the other lies within the proline rich region. Taken together, these results show that the novel juxtaposition of env gene sequences enhanced the infectivity of PERV-A14/220 for human cells, perhaps by stabilization of the envelope glycoprotein or increased receptor binding.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-10590090, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-10762107, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-10906195, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11222699, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11222700, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11356953, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11435563, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11680007, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11818467, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11861871, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-11983017, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12185278, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12388691, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12388734, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12477819, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12588647, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12740431, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-12795683, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-14517066, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-14671113, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-14963150, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-14963152, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-15564496, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-1733113, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-1847454, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-191826, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-3039159, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-4579634, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-6165830, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-6270351, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-7684467, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-7899083, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-8892960, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-9055854, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-9338777, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-9525633, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-9620992, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-9811733, http://linkedlifedata.com/resource/pubmed/commentcorrection/15564495-9811736
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13871-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Determinants of high titer in recombinant porcine endogenous retroviruses.
pubmed:affiliation
National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't